Government of India’s track and trace system enables authentication and verification of pharmaceuticals exported from India
For continued confidence in exported pharmaceuticals from India, Director General of Foreign Trade (DGFT) vide public notice number 52/2015-2020, outlines the requirements for a track and trace system that enables traceability of exported pharmaceutical consignments in order to prevent counterfeits.
Per the notice, exporters are required to mark consignments with GS1 barcodes at various packaging levels and upload this information along with product hierarchy (parent-child relationship) to the Drug Authentication and Verification Application (DAVA), before the consignment is released for sale or distribution.
Designed by National Informatics Centre (NIC), DAVA is based on GS1 standards, which make it possible to uniquely identify, capture and share important information about exported consignments with Regulators and patients across the world.
DAVA has a mobile app version as well, which allows manufacturers and exporters to confirm their export consignment data has successfully uploaded to the DAVA portal. Regulators and patients anywhere in the world can also use the app to authenticate Indian pharmaceuticals and drugs by simply scanning barcode labels on secondary and tertiary packaging levels. Download the DAVA mobile app for Android.
More than 380 large and medium sized pharmaceutical companies upload their daily production data to DAVA with the number growing. GS1 India works closely with NIC & DGFT to support the implementation of this application. DAVA case study.
How DAVA works?